Medical Devices & Biologics Projects in India – Page 22
236 upcoming and ongoing medical devices & biologics projects in India worth ₹50,583 Cr, with investment, location, project stage and latest status. Last updated 17 Sep 2026.
Projects tracked
236
Total investment
₹50,583 Cr
Pre-project / Under construction
0 / 0
Added in the last 30 days
3
Latest medical devices & biologics projects in India
Showing 106–110 of 236
Project Work CommencedMedical Devices & BiologicsUpdated
A dental filling material manufacturing project in Telangana's Medical Devices Park approved, with a capacity of 300,000 units/month. Cost: Rs. 132.9M. State pollution authorities granted consent in Feb '24, ensuring environmental compliance.
A surgical and medical products manufacturing project in Behrampur, Gurugram, Haryana, with an estimated cost of Rs.78.8 million. The project has received consent from state pollution control authorities for establishment as of January 2024.
A company is planning to set up a greenfield animal vaccine manufacturing facility in Genome Valley, Hyderabad, Telangana, to make Foot and Mouth disease and other emerging diseases. The estimated cost of the project is Rs. 7000 million and as of October 2022, pre-project activities are underway.
A leading syringe manufacturer is set to launch a new vial and syringe manufacturing project at a facility in Thane, Maharashtra. With a production capacity of 10,000 vials and 1,000 syringes per day, the project is estimated to cost Rs.58.967 million. The company has obtained approval from state pollution control authorities as of January 2024.
A pharmaceutical company plans to expand its R&D unit in Uppal, Nacharam, Telangana, with a project cost of Rs.1827.4 million. Having secured consent from pollution control authorities in January 2022, the expansion aims to drive local economic growth, generate employment, and contribute to Telangana's flourishing pharmaceutical sector. The state government's support and industry-focused initiatives make Telangana an appealing hub for pharmaceutical companies. As of January 2024, the R&D unit expansion involves an investment of Rs.2571.069 million, with approved consent from pollution control authorities.